ADIL

Conviction 80HealthcareScan · Thu, Jun 25, 2026

ADIL$2.56+3.23%

ResistanceSupportVol 14Insider buy

Vol MA14 1.68M

Mar 26Apr 14May 1May 19Jun 8Jun 25

ADIAL PHARMACEUTICALS, INC.PHARMACEUTICAL PREPARATIONSwww.adial.com ↗

Price2.56

Change+3.23%

Gap-0.40%

Rel volume0.49×

Avg volume1.19M

Avg $ vol3.51M

SMA 202.51

SMA 502.01

SMA 2001.14

Price vs 50+27.55%

Price vs 200+124.11%

MA stackbullish

50/200 cross—

Supertrendup · 2.28

RSI (14)55

MACD hist-0.03

MACD crossbear · 2d

Stoch %K / %D15 / 14

ADX (14)50

+DI / −DI36 / 12

RSI divergence—

MACD divergence—

ATR %+14.00%

ADR %14.24%

52w high3.12

52w low0.1370

From 52w high-17.95%

Above 52w low+1768.61%

New 52w highNo

SqueezeOff

Bollinger width39.02%

%B0.55

Donchian pos14.71%

Donchian high5.17

Donchian low2.11

AVWAP (52w high)3.34

vs AVWAP high-23.42%

AVWAP (52w low)2.81

vs AVWAP low-9.00%

OBV trendUp

Chaikin MF (20)-0.36

Today vs 20d0.49×

Avg vol (14d)1.68M

Avg vol (20d)1.19M

Avg $ vol (20d)3.51M

Market cap5.49M

RS 3m (vs SPY)+34.49%

RS 6m (vs SPY)+923.45%

RS line new highNo

Trend template8/8

Technical rank90.2

1 week-6.91%

1 month+14.29%

3 months+47.98%

6 months+966.67%

1 year+1016.44%

YTD+969.79%

P/E-0.69

P/B1.48

P/S—

P/FCF-0.84

EPS-11.93

Div yield—

ROE-214.60%

ROA-152.61%

Debt/Eq—

Current3.18

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth39.56%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value-393.55K

Revenue—

Net income-2.02M

Gross profit—

Free cash flow-6.56M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out2.14M

Employees6

ListedFri, Jul 27, 2018

Free float1.41M

Float %98.6%

Short interest47.29K

Days to cover0.1d

Short volume28.8%

Squeeze score7 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction80 / 100

Pattern quality—

Tech rank90.2 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance3.87

Support1.35

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ADIL

All disclosures →

No recent disclosed trades by Congress in ADIL. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ADIL · 9 buys

Insider	Side	Shares	Value	Traded	Filed
Davidson Matt Chief Development Officer · Common Stock · 2026-06-12	Grant	232.42K	—	2026-06-12	2026-06-16
Davidson Matt Chief Development Officer · Stock Option (Right to Buy) · 2026-06-12	Grant	232.42K	—	2026-06-12	2026-06-16
Young Wendy B. Director · Pre-funded Warrant · 2026-06-12	Buy	36.38K	$100K	2026-06-12	2026-06-16
Davidson Matt Chief Development Officer · Series A Preferred Stock · 2026-06-11	Grant	101.298	—	2026-06-11	2026-06-16
Davidson Matt Chief Development Officer · Series A Preferred Stock · 2026-06-11	Grant	1.82K	—	2026-06-11	2026-06-16
Davidson Matt Chief Development Officer · Common Stock · 2026-06-11	Grant	3.43K	—	2026-06-11	2026-06-16
Davidson Matt Chief Development Officer · Common Stock · 2026-06-11	Grant	61.65K	—	2026-06-11	2026-06-16
Schuyler Kevin Director · Common Stock · 2026-04-07	Other	—	—	2026-04-07	2026-04-09
Goodman Tony Chief Operating Officer · Common Stock · 2026-04-07	Grant	26.51K	$0	2026-04-07	2026-04-09
Gilliland Robertson H. Director · Common Stock · 2026-04-07	Grant	9.19K	$0	2026-04-07	2026-04-09

SEC filings

EDGAR filings in ADIL · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.